Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Fillat

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Progress in Brain Research|May 1, 2012
Gene therapy for Down syndromeCristina Fillat, Xavier Altafaj
Scientific Reports|June 10, 2016
Codon optimization of the adenoviral fiber negatively impacts structural protein expression and viral fitnessEneko Villanueva, Maria Martí-Solano, Cristina Fillat
Cancers|April 29, 2020
Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic AdenovirusesMartí Farrera-Sal, Cristina Fillat, Ramon Alemany
International Journal of Molecular Medicine|September 6, 2007
Novel membrane cell projection defects in Wiskott-Aldrich syndrome B cellsNuria Andreu, Josep M Aran, Cristina Fillat
Oncotarget|February 26, 2015
Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cellsXavier Bofill-De Ros, Eneko Villanueva, Cristina Fillat
International Journal of Molecular Medicine|March 29, 2007
Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopeniaNuria Andreu, Núria Matamoros, Antonio Escudero, et al.
Cancer Letters|November 15, 2011
Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse modelsAnabel José, Luciano Sobrevals, Antoni Ivorra, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2014
miR-148a- and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activityXavier Bofill-De Ros, Meritxell Gironella, Cristina Fillat
Frontiers in Oncology|July 21, 2017
Implications of MicroRNAs in Oncolytic VirotherapyXavier Bofill-De Ros, Maria Rovira-Rigau, Cristina Fillat
Human Gene Therapy|March 14, 2009
Antitumor therapy based on cellular competitionJordi Martinez-Quintanilla, Manel Cascallo, Cristina Fillat, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Progress in Brain Research|May 1, 2012
Gene therapy for Down syndromeCristina Fillat, Xavier Altafaj
Scientific Reports|June 10, 2016
Codon optimization of the adenoviral fiber negatively impacts structural protein expression and viral fitnessEneko Villanueva, Maria Martí-Solano, Cristina Fillat
Cancers|April 29, 2020
Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic AdenovirusesMartí Farrera-Sal, Cristina Fillat, Ramon Alemany
International Journal of Molecular Medicine|September 6, 2007
Novel membrane cell projection defects in Wiskott-Aldrich syndrome B cellsNuria Andreu, Josep M Aran, Cristina Fillat
Oncotarget|February 26, 2015
Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cellsXavier Bofill-De Ros, Eneko Villanueva, Cristina Fillat
International Journal of Molecular Medicine|March 29, 2007
Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopeniaNuria Andreu, Núria Matamoros, Antonio Escudero, et al.
Cancer Letters|November 15, 2011
Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse modelsAnabel José, Luciano Sobrevals, Antoni Ivorra, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2014
miR-148a- and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activityXavier Bofill-De Ros, Meritxell Gironella, Cristina Fillat
Frontiers in Oncology|July 21, 2017
Implications of MicroRNAs in Oncolytic VirotherapyXavier Bofill-De Ros, Maria Rovira-Rigau, Cristina Fillat
Human Gene Therapy|March 14, 2009
Antitumor therapy based on cellular competitionJordi Martinez-Quintanilla, Manel Cascallo, Cristina Fillat, et al.
Pageof 9